Over 580,000 bottles of blood pressure medication made by Teva Pharmaceuticals have been recalled by the U.S. Food and Drug Administration (FDA) due to elevated levels of a potential carcinogenic impurity.
The affected medication is prazosin hydrochloride, with recalled bottles including 1 milligram (mg), 2 mg, and 5 mg capsules.
The recall was issued after certain lots of the medication tested positive for the impurity, which is a byproduct of the manufacturing process.
It is essential to consult a physician before stopping the medication, even if the bottles are affected.
Consult your physician before stopping a medication—even if you’re concerned that your bottles are affected.
Affected bottles can be identified by lot number and expiration date, as outlined in the FDA report.
Author summary: Recall of blood pressure medication due to carcinogenic impurity.